Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | UTS2R | Q9UKP6 | 4/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HRH3 | Q9Y5N1 | 9/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3643345 | 0.93 | UTS2R (0.40) | ATMUTS2RMAPK1HRH3ALDH1A1 | |
| SCHEMBL3647355 | 0.91 | HRH3 (0.45) | ATMUTS2RMAPK1HRH3 | |
| SCHEMBL3808822 | 0.87 | HRH3 (0.40) | HRH3 | |
| SCHEMBL3814095 | 0.87 | MEN1 (0.40) | ATMMAPK1HRH3ALDH1A1 | |
| SCHEMBL3814183 | 0.86 | MAPK1 (0.51) | ATMUTS2RMAPK1HRH3ALDH1A1 | |
| SCHEMBL3647308 | 0.85 | UTS2R (0.41) | UTS2RHRH3 | |
| SCHEMBL3646727 | 0.84 | HRH3 (0.45) | UTS2RHRH3 | |
| SCHEMBL3647988 | 0.83 | HRH3 (0.42) | ATMMAPK1HRH3ALDH1A1 | |
| SCHEMBL4017237 | 0.83 | HRH3 (0.44) | UTS2RHRH3 | |
| SCHEMBL4017683 | 0.82 | HRH3 (0.46) | ATMMAPK1HRH3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2183237-A1 | BENZOFURAN- AND BENZO[B]THIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AND USE THEREOF AS HISTAMINE 3 RECEPTOR MODULATORS | F. Hoffmann-Roche AG (CH) | 2010-05-12 | — | — | EP | disclosed |
| WO-2009013195-A1 | BENZOFURAN- AND BENZO[B]THIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AND USE THEREOF AS HISTAMINE 3 RECEPTOR MODULATORS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-01-29 | — | — | WO | disclosed |